About Menarini Group
Menarini Group is a company based in Florence (Italy). It operates as a Direct-to-Consumer (D2C) and Professional Services. Menarini Group has completed 3 acquisitions, including Orbactiv, Silicon Biosystems and Stemline Therapeutics. Menarini Group offers products and services including Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine. Menarini Group operates in a competitive market with competitors including Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
- Headquarter Florence, Italy
- SectorsHealthcare
- Phone•••• ••••
- Website menarini.com
- Social LinkedIn X YouTube
- Legal Name A. Menarini Industrie Farmaceutiche Riunite Srl
- Investments & AcquisitionsOrbactiv
& 2 more
Products & Services of Menarini Group
Menarini Group offers a comprehensive portfolio of products and services, including Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine.
Medicines are developed for various therapeutic areas.
Products are offered for everyday health needs.
Therapies are provided for cancer patient care.
Solutions are created for professional diagnostic needs.
Products are designed for skin and aesthetics.
Apps and channels of Menarini Group
its YouTube channel Menarini Group has 709 subscribers and 30 videos.
Videos from Menarini Group
The most watched videos on Menarini Group's YouTube channel, Menarini Group (709 subscribers). Click a video to play it here.
More on Menarini Group.
People of Menarini Group
37 people are tracked at Menarini Group (14 in leadership, 5 in board & advisors, 18 in team).
| Name | Role | Group |
|---|---|---|
Ennio Troiano | Global Head of Human Resources | Leadership |
Elcin Barker Ergun | Group CEO | Leadership |
Pietro Giovanni Corsa | General Manager, Global Head of Finance, Administration, IT and Procurement | Leadership |
Luca Lastrucci | General Manager, Global Head Medico Marketing and Sales, Pharmaceuticals | Leadership |
Nassir Habboubi | Global Head of R&D, Menarini Stemline | Leadership |
Fabio Piazzalunga | Global Head of Diagnostics & CEO of Menarini Silicon Biosystems | Leadership |
Jose Miguel Garcia Lozano | Director DE Logistica Y Compras | Leadership |
Joaquim Puig de Dou | Director Market Access & Public Affairs | Leadership |
Antoni Zapata | Medical Director Deputy | Leadership |
Ivan Bergstein | President & CEO of Stemline Therapeutics | Leadership |
Ignacio Gonzalez Casteleiro | General Manager Spain | Leadership |
Francesc Boada Monjonell | Finance Director | Leadership |
Sergio Chellini | Global Head of Legal and General Affairs | Leadership |
Alberto Mastantuono | Global Head of Medico Marketing Strategy | Leadership |
Eric Cornut | Chairman | Board & advisors |
Lucia Aleotti | Director | Board & advisors |
Alberto Giovanni Aleotti | Director | Board & advisors |
Juerg Witmer | Director | Board & advisors |
Carlo Colombini | Director | Board & advisors |
Almudena Gomez-Guiu | Patient Engament Manager And Scientific Advisor Market Access | Team |
17 more people are available in the full profile.
Complete people profiles for Menarini Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Menarini Group
Menarini Group has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Orbactiv, Silicon Biosystems and Stemline Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Novel oncology therapeutics targeting cancer stem cells are developed. | stemline.com | New York, United States | 2003 | May 2020 | •••• | |
Developer of a single-dose antibiotic for bacterial skin infections. This antibiotic offers an alternative treatment for acute bacterial skin and skin structure infections caused by specific gram-positive microorganisms. It provides a single-dose option compared to multiple-dose regimens, and the company offers support programs for insurance verification, billing, and patient assistance. The product has three mechanisms of action and is indicated for adult patients. Important safety information includes potential interactions with anticoagulants and the need for monitoring of certain coagulation tests. Adverse reactions are documented in the full prescribing information. | orbactiv.com | United States | 2014 | Oct 2018 | •••• | |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed. | siliconbiosystems.com | Bologna, Italy | 1999 | Sep 2013 | $66.38M |
Complete acquisition details for Menarini Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Menarini Group
3 dated milestones of Menarini Group across 7 years, from founding to its latest funding, stage changes and deals.
- Acquisition Acquires Silicon Biosystems.
- Acquisition Acquires Orbactiv.
- Acquisition Acquires Stemline Therapeutics.
Competitors of Menarini Group
Menarini Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, Gilead, Lilly and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| merck.com | 1891 | Kenilworth, United Kingdom | – | 781 | Pharmaceutical products are manufactured and marketed worldwide. | |
| roivant.com | 2014 | New York, United States | $1.3B | 662 | Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | |
| gilead.com | 1987 | Foster, United States | – | 4,267 | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | |
| lilly.com | 1876 | United States | – | 39,000 | Traditional pharmaceutical medicines are developed for multiple health fields. | |
| vrtx.com | 1989 | United States | – | 5,400 | Developer of drugs for the treatment of multiple disorders | |
| abbvie.com | 2012 | Chicago, United States | – | 8,667 | Biopharmaceutical research and drug development are conducted globally by AbbVie. | |
| morphosys.com | 1992 | Planegg, Germany | – | 732 | Therapeutic antibodies for cancer and other diseases are developed. | |
| roche.com | 1896 | Basel, Switzerland | – | 2,382 | Pharmaceuticals and diagnostics kits are developed for various diseases. | |
| unither.com | 1998 | Silver Spring, United States | – | 1,168 | Treatments for chronic and life-threatening diseases are developed and commercialized. | |
| ascendispharma.com | 2007 | Hellerup, Denmark | $108.7M | 573 | Long-acting prodrug therapies are developed for endocrine and rare diseases. |
Detailed competitors of Menarini Group
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Menarini Group
Websites that share an audience with Menarini Group (menarini.com).
Websites whose visitors overlap most with Menarini Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neclife.com | 96% | 4.6K | #4,844,386 | View details | |
| bioagilytix.com | 80% | 41.6K | #919,146 | View details | |
| reszonics.com | 62% | 2.2K | #7,362,868 | View details |
Latest news on Menarini Group
Complete news archive for Menarini Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Menarini Group
10 companies that operate in the same segment as Menarini Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Menarini Group
Menarini Group is headquartered in Florence, Italy.
Menarini Group is involved in the development and distribution of pharmaceutical products across various therapeutic areas, including oncology, cardiometabolic, and respiratory health. The company is also active in consumer healthcare, diagnostics, and dermatology. Research and innovation are prioritized to address serious health conditions. With a global presence, strategic partnerships are established to enhance product reach and impact. Sustainability and social responsibility are integrated into operations to support communities and environmental initiatives.
Menarini Group's top competitors include Merck, Roivant Sciences and AbbVie.
Menarini Group offers Pharmaceuticals, Consumer Healthcare, Oncology Treatments, Diagnostics, and Dermatology and Aesthetic Medicine.
Menarini Group has made 3 acquisitions, including Orbactiv, Silicon Biosystems, and Stemline Therapeutics.
Menarini Group operates through A. Menarini Industrie Farmaceutiche Riunite Srl.